Brodalumab Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Brodalumab has been used in trials studying the treatment of Asthma, Psoriasis, Crohn's Disease, Psoriatic Arthritis, and Rheumatoid Arthritis. Brodalumab was FDA approved in February, 2017 as Siliq for the treatment of moderate-to-severe plaque psoriasis.
Brodalumab Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte